Abstract

Cardiovascular Disease: an alarming health problem

Cardiovascular Disease: the need for change in the drug industry

Drug discovery and toxicology: seeking a reliable test system

Stem-cell-derived cardiomyocytes: paving the way to safer and more effective cardiovascular medicines

The potential of human embryonic stem-cell-derived (hESC) cardiomyocytes

iPSCs – transforming the outlook of cardiovascular diseases

Current applications of human pluripotent stem cells in drug screening

Obstacles in the face of stem cell technology

Looking forward

Concluding Remarks

References